How middle-market healthcare companies can build climate value, resilience, and competitive advantage
In the recent SLR article “Decarbonizing Healthcare: Where to Focus in the Middle Market“, co-authored by Malk’s experts, we examine how healthcare firms positioned between large multinationals and smaller providers can meaningfully reduce emissions without overextending scarce resources. Middle-market healthcare businesses are often under pressure – from regulators, customers, and investors – to measure, disclose, and reduce greenhouse gas emissions, but they typically lack the depth of sustainability staff or the scale of investment found in larger firms. This analysis identifies the foundational moves they must take: benchmarking emissions hotspots; singling out the products or relationships that drive most of the footprint; and mapping those to business value in order to build decarbonization into planning and operations.
What sets the middle market apart is its agility – and opportunity. Our article outlines how investors and management teams can unlock value from supplier engagement, renewable energy sourcing, life-cycle assessment readiness, and standard-setting. Connecting emissions reductions to revenue risk, contract compliance, and exit valuations not only mitigates risk, but creates new sources of competitive differentiation. By integrating decarbonization into their value-creation strategies – and leveraging coalitions, shared frameworks, and credible metrics – middle market healthcare firms can align sustainability and business performance in a way that drives both impact and long-term returns. If you’d like to explore how your company could apply these lessons or shape its decarbonization roadmap, read the full insight on SLR’s website.